Recipients given B-BCL6+/+ or B-BCL6−/− TCD-BM cells (2.5 × 106) alone showed no signs of GVHD (B-BCL6+/+ or B-BCL6−/− no GVHD). Here, BCL6 is linked to graft versus host disease.